1979192-13-6
Chemical Structure
REV7/REV3L-IN-1
- CAS No.: 1979192-13-6
- Formula:C19H21N3O3S
- Molecular Weight:371.45
IUPAC Name: 3-((1-acetylpiperidin-4-yl)methyl)-5-(5-methylfuran-2-yl)thieno[2,3-d]pyrimidin-4(3H)-one
InChIKey: FCAGATFCNDPZOG-UHFFFAOYSA-N
SMILES: O=C(C)N1CCC(CN2C=NC(SC=C3C4=CC=C(C)O4)=C3C2=O)CC1
Biological Activity: REV7/REV3L-IN-1 is a REV7/REV3L interaction inhibitor with an IC50 of 78 μM. REV7/REV3L-IN-1 binds directly to REV7 and inhibits its interaction with REV3L. REV7/REV3L-IN-1 inhibits interstrand crosslink repair in cells. REV7/REV3L-IN-1 chemosensitizes cancer cells to Cisplatin (HY-17394). REV7/REV3L-IN-1 can be used in cervical cancer research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
REV7/REV3L-IN-1 | 98.11% | REV7/REV3L-IN-1 is a REV7/REV3L interaction inhibitor with an IC50 of 78 μM. REV7/REV3L-IN-1 binds directly to REV7 and inhibits its interaction with REV3L. REV7/REV3L-IN-1 inhibits interstrand crosslink repair in cells. REV7/REV3L-IN-1 chemosensitizes cancer cells to Cisplatin (HY-17394). REV7/REV3L-IN-1 can be used in cervical cancer research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
REV7/REV3L-IN-1 (Standard) | ≥98% | REV7/REV3L-IN-1 (Standard) is the analytical standard of REV7/REV3L-IN-1 (HY-100468). This product is intended for research and analytical applications. REV7/REV3L-IN-1 is a REV7/REV3L interaction inhibitor with an IC50 of 78 μM. REV7/REV3L-IN-1 binds directly to REV7 and inhibits its interaction with REV3L. REV7/REV3L-IN-1 inhibits interstrand crosslink repair in cells. REV7/REV3L-IN-1 chemosensitizes cancer cells to Cisplatin (HY-17394). REV7/REV3L-IN-1 can be used in cervical cancer research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
